A hydrogel wound dressing loaded with antimicrobial peptide MSI-1 and photothermal nanoparticles killed bacteria for 24 hours and disrupted biofilms with near-infrared light while remaining safe for healthy cells.
>90% cell survivalThe dual-mode antimicrobial hydrogel maintained biocompatibility while effectively killing bacteria for 24 hours
What the researchers found
The MSI-1 antimicrobial peptide was covalently attached to a chitosan/polyvinyl alcohol hydrogel containing Prussian blue nanoparticles (PBNPs). The dual-mode system demonstrated:
- Sustained bactericidal activity against S. aureus and E. coli for 24 hours through the antimicrobial peptide surface
- Photothermal heating to 48.3°C within 10 minutes under 808 nm near-infrared light, sufficient to disrupt bacterial biofilms
- Over 90% cell survival in co-culture for 3 days, indicating biocompatibility
- No damage to major organs in animal experiments
The mild photothermal temperature avoids thermal damage to healthy tissue while still being effective against biofilms.
Why it matters
Infected wounds are a major healthcare problem, especially as antibiotic resistance grows. Biofilm formation makes infections even harder to treat. This dressing attacks the problem from two angles — an antimicrobial peptide for killing individual bacteria and photothermal treatment for disrupting the protective biofilm structures that make infections chronic.
How the study worked
The antimicrobial peptide MSI-1 was covalently linked to chitosan-modified PVA hydrogels through amine-carboxyl coupling. Prussian blue nanoparticles were incorporated for photothermal capability. Antimicrobial activity was tested against S. aureus and E. coli. Photothermal performance was characterized under 808 nm NIR light. Biocompatibility was assessed through cell co-culture and animal organ toxicity studies.
What this study cannot tell us
In vitro and animal testing only — human clinical trials have not been conducted. The photothermal component requires an external NIR light source, adding complexity to clinical use. Only two bacterial species were tested. Long-term stability and shelf life of the peptide-loaded hydrogel were not assessed. The 48.3°C photothermal temperature needs careful control to avoid tissue damage in clinical settings.
How to read the evidence
This is a preclinical materials science study with in vitro antimicrobial testing and basic animal safety assessment. The dual-mode concept is well-demonstrated but needs clinical validation.
When this study was published
Published in 2025 in Carbohydrate Polymers, this is a recent contribution to the growing field of antimicrobial peptide-based wound care materials.
The bigger picture
Antimicrobial peptide-functionalized wound dressings are an active area of research as alternatives to antibiotic-loaded dressings. Combining peptide antimicrobial activity with photothermal biofilm disruption represents a multi-modal approach that could be particularly effective for chronic infected wounds that resist conventional treatment.
Questions still open
- How does this dual-mode dressing perform against antibiotic-resistant bacteria like MRSA?
- Could the photothermal component be triggered by a simple handheld device for practical clinical use?
- How does the cost of this peptide-loaded hydrogel compare to conventional wound dressings?
Common questions
What is MSI-1 and how does it kill bacteria?
How does the photothermal feature work?
Read the original research
Co-delivery of antimicrobial peptide and Prussian blue nanoparticles by chitosan/polyvinyl alcohol hydrogels.
Carbohydrate polymers, 348(Pt A), 122873
Citation
Liao, Zhiyi; Li, Jiayi; Ni, Wenqiang; Zhan, Rixing; Xu, Xisheng. (2025). Co-delivery of antimicrobial peptide and Prussian blue nanoparticles by chitosan/polyvinyl alcohol hydrogels.. Carbohydrate polymers, 348(Pt A), 122873. https://doi.org/10.1016/j.carbpol.2024.122873